| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/27/2009 | US20090214516 Inhibitors of Reglll Proteins as Asthma Therapeutics |
| 08/27/2009 | US20090214515 Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins |
| 08/27/2009 | US20090214492 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 08/27/2009 | US20090214476 Novel mannose-specific adhesins and their use |
| 08/27/2009 | US20090214467 Methods of protecting against apoptosis using lipopeptides |
| 08/27/2009 | US20090214463 Latent phase viral interleukin-10-(VII-10) and uses thereof |
| 08/27/2009 | US20090214444 Poly aromatic sodium channel blockers |
| 08/27/2009 | US20090214431 Identification of ergothioneine transporter and therapeutic uses thereof |
| 08/27/2009 | US20090214427 Novel peptides |
| 08/27/2009 | US20090214422 DNA encoding a novel RG1 polypeptide |
| 08/27/2009 | DE102008010954A1 DNA-Vakzine zur Therapie und Prophylaxe von Gebärmutterhalskrebs und seinen prämalignen Vorstufen DNA vaccine for the therapy and prophylaxis of cervical cancer and its precursors premalignant |
| 08/27/2009 | DE102004059633B4 Promotoren und deren Verwendung Promoters and their use |
| 08/27/2009 | CA2844188A1 Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof |
| 08/27/2009 | CA2754352A1 Postsynaptically targeted chemodenervation agents and their methods of use |
| 08/27/2009 | CA2752851A1 Treatment and prevention of dry age-related macular degeneration by activating cd36 |
| 08/27/2009 | CA2716392A1 Mntf peptide compositions and methods of use |
| 08/27/2009 | CA2716280A1 Biomarkers |
| 08/27/2009 | CA2716255A1 Cosmetic and dermatological formulations of mntf peptides |
| 08/27/2009 | CA2716212A1 Meningococcal fhbp polypeptides |
| 08/27/2009 | CA2716210A1 Escherichia coli immunogens with improved solubility |
| 08/27/2009 | CA2715940A1 Oligopeptidic compounds and uses thereof |
| 08/27/2009 | CA2715924A1 Optimisation of expression of parvoviral rep and cap proteins in insect cells |
| 08/27/2009 | CA2715875A1 Method of treating ocular diseases by gene therapy |
| 08/27/2009 | CA2715324A1 Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof |
| 08/27/2009 | CA2713872A1 Methods and compositions related to peptides and proteins with c-terminal elements |
| 08/27/2009 | CA2709907A1 Peptide derived from neurotensin receptor 3 and use thereof in the treatment of psychiatric diseases |
| 08/27/2009 | CA2707029A1 Simian subfamily c adenoviruses sadv-40, -31, and-34 and uses thereof |
| 08/26/2009 | EP2093570A1 Modulating the interaction between HGF beta chain and c-met |
| 08/26/2009 | EP2093298A2 Compositions for diagnosis and therapy of diseases associated with aberrant expression of Futrins (R-Spondins) |
| 08/26/2009 | EP2093294A1 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 08/26/2009 | EP2093293A2 G-Protein coupled receptors |
| 08/26/2009 | EP2093281A1 Protein nanocarriers, process for obtaining them and applications |
| 08/26/2009 | EP2093235A1 Hyperglycosylated variants of interferon alfacon-1 |
| 08/26/2009 | EP2093233A1 Novel compositions and methods in cancer |
| 08/26/2009 | EP2092938A1 Survivin-derived peptides and use thereof |
| 08/26/2009 | EP2092937A2 Immunotherapeutic and immunoprophylactic reagents |
| 08/26/2009 | EP2092343A1 Detection conjugate |
| 08/26/2009 | EP2092335A1 A homogeneous time resolved fluorescence based test system for paramyxoviridae |
| 08/26/2009 | EP2092069A2 Modified soluble fgf receptor fc fusions with improved biological activity |
| 08/26/2009 | EP2092068A2 Optimized non-canonical zinc finger proteins |
| 08/26/2009 | EP2091972A1 Multi-modal cancer therapy using viral hitch-hiking |
| 08/26/2009 | EP2091968A2 Il-21 variants |
| 08/26/2009 | EP2091967A1 Crystalline composition of gm-csf/gm-csfr |
| 08/26/2009 | EP2091966A2 Promoter construct |
| 08/26/2009 | EP2091965A1 Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides |
| 08/26/2009 | EP2091964A2 Targeting nbs1-atm interaction to sensitize cancer cells to radiotherapy and chemotherapy |
| 08/26/2009 | EP2091963A2 New antigens for paratuberculosis diagnosis and vaccination |
| 08/26/2009 | EP2091962A2 Cells and methodology to generate non-segmented negative-strand rna viruses |
| 08/26/2009 | EP2091961A2 Multi-epitope peptide-loaded dendritic cell immunotherapy for cancer |
| 08/26/2009 | EP2091960A2 Peptide vaccine for influenza virus |
| 08/26/2009 | EP2091562A1 Il- 18 vaccine for the treatment of various inflammatory conditions. |
| 08/26/2009 | EP2091554A2 Use of polypeptides as coccidiostat and /or histomonastat |
| 08/26/2009 | EP2091553A2 Casein-derived peptides having anxiolytic activity |
| 08/26/2009 | EP2032992B1 Method for the selective determination of procalcitonin 1-116 for diagnostic purposes and antibodies and kits for carrying out such a method |
| 08/26/2009 | EP1891104B1 Solid phase bound thymosin alpha1 and its synthesis |
| 08/26/2009 | EP1888096A4 Milk fat globule epidermal growth factor-factor viii and sepsis |
| 08/26/2009 | EP1730499B1 Method for the detection of intracellular parameters with luminescent protein probes for the screening of molecules capable of altering said parameters |
| 08/26/2009 | EP1711530B1 Nogo-a neutralising immunoglobulins for treatment of neurological diseases |
| 08/26/2009 | EP1624885A4 Synthetic peptide analogs of arg-pro-pro-gly-phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4 |
| 08/26/2009 | EP1601694B1 Uses of il-23 antagonists; related reagents |
| 08/26/2009 | EP1561759B9 Cell death-inducing agent |
| 08/26/2009 | EP1530584B1 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses |
| 08/26/2009 | EP1503780B1 Androgen-regulated pmepa1 gene and methods of using the same to inhibit cancer cell growth |
| 08/26/2009 | EP1478328A4 Bioactive keratin peptides |
| 08/26/2009 | EP1451207B1 Labeling reagent and methods of use |
| 08/26/2009 | EP1450855B1 Suppression of allergic reactions by transdermal administration of allergens in conjunction with or conjugated to toxin subunits or fragments thereof |
| 08/26/2009 | EP1297005B1 Immunisation against chlamydia pneumoniae |
| 08/26/2009 | EP1282636B1 Trp8, a transient receptor potential channel expressed in taste receptor cells |
| 08/26/2009 | EP1237915B1 Polynucleotid encoding the rg1 polypeptide |
| 08/26/2009 | EP1200592B1 Mammalian cytokines; related reagents |
| 08/26/2009 | EP1147212B1 T helper cell epitopes |
| 08/26/2009 | EP1066324B1 Novel mammalian g-protein coupled receptors having extracellular leucine rich repeat regions |
| 08/26/2009 | EP1037977B1 EXTENDED cDNAs FOR SECRETED PROTEINS |
| 08/26/2009 | EP1025218B9 Libraries of human antibody polypetides |
| 08/26/2009 | EP1012187B1 Chemokine peptides, variants, derivatives and analogs. their use in methods to inhibit or augment an inflammatory response |
| 08/26/2009 | EP1007700B1 Monoclonal antibody against a prion protein and its use for the detection of prions |
| 08/26/2009 | EP0774120B1 Peptides marked with metal chelates |
| 08/26/2009 | CN101516909A CD4-receptor-derived peptides and method for the preparation thereof |
| 08/26/2009 | CN101516908A Nucleic acids for expressing a polynucleotide of interest in mammalian cancer cells |
| 08/26/2009 | CN101516907A Muteins of tear lipocalin and methods for obtaining the same |
| 08/26/2009 | CN101516906A Methods of increasing secretion of polypeptides having biological activity |
| 08/26/2009 | CN101516905A Borrelia antigens |
| 08/26/2009 | CN101516902A Polypeptides and polynucleotides encoding same and use thereof in the treatment of medical conditions associated with ischemia |
| 08/26/2009 | CN101516857A Labelling of fusion proteins with synthetic probes |
| 08/26/2009 | CN101516395A A vaccine for chikungunya virus infection |
| 08/26/2009 | CN101516391A Methods for administering long-lasting hypoglycemic agents |
| 08/26/2009 | CN101514354A Sea cucumber polypeptide, preparation method and application thereof |
| 08/26/2009 | CN101514342A Rice cytoplasmic male sterile genes and application thereof |
| 08/26/2009 | CN101514341A Isolated photoprotein mtClytin, and use thereof |
| 08/26/2009 | CN101514334A Chicken infectivity bronchitis virus attenuated vaccine strain and application thereof |
| 08/26/2009 | CN101514229A Human interferon alpha derivative and polyethylene glycol modified substance thereof |
| 08/26/2009 | CN101514228A N-terminal modified human thymosin alfa 1 compound and preparation method thereof |
| 08/26/2009 | CN101514227A Extraction process for amylase inhibiting protein |
| 08/26/2009 | CN101514226A Method for extracting pine nut protein of Korean pine |
| 08/26/2009 | CN101514223A Method for preparation of site-specific protein conjugates |
| 08/26/2009 | CN100532562C Insect resistant plants and methods for producing the plant |
| 08/26/2009 | CN100532561C New glucoamylase and nucleic acid sequence coding same |
| 08/26/2009 | CN100532558C Optimizing glycan processing in plants |
| 08/26/2009 | CN100532555C Highly efficient cry8F gene for Coleoptera pest, expression protein and application thereof |
| 08/26/2009 | CN100532553C Amylose content control gene DU1 of rice endosperm and application thereof |